Ann: Becoming a substantial holder, page-3

Who knows if they are shorting “experts” but we do know they play both sides of the game. They just threw in one million in the most recent placement it seems and have already disposed of ~85m share between their issue of shares and the 8/1/24, which oddly isn’t represented in the anexure 2 of the disclosure.

At .005 the company is worth 22m fully diluted including 2m from spp. total cash balance around 19m from beginning of this month. The company has been in similar positions albeit at different price levels as the dilution is absorbed and expenditure reaches commencement of p2 trial dosing. Unless the company comes up with some news, I reckon price capped at .007 for the time being with a .003 floor.

In any case I’m putting in another order tomorrow at .004 as I think regal or the revelation of regal on the register might bring that price point into play. anything at or below this price point should be ok as the sp stagnates between .003-.005 until any ray of sunshine appears from this endless dark night Ath seems to be perpetually engulfed in.

Otherwise, can you shed any light on anything scientific the company is actually working on that may lead someone to get excited about? perhaps something outside of the many papers you like to post here and the fund you like to spruik so that it’s more specific to any current ATH work in progress?